Comparison Chart Neurocrine Biosciences, Inc.

NBIX

US64125C1099

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	NEUROCRINE BIOSCIENCES, INC.	Other Pharmaceuticals	-1.16%	-3.12%	-9.66%	+13.35%	+37.43%	1.29TCr

Market Closed - Nasdaq Other stock markets 02:30:00 07/03/2026 am IST			5-day change	1st Jan Change
128.13 ^USD	-1.16%		-3.12%	-9.66%

04/03	Neurocrine Biosciences, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 11:50 AM
13/02	UBS Adjusts Price Target on Neurocrine Biosciences to $161 From $178, Maintains Buy Rating	MT

Comparison Chart Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Pharmaceuticals

Compared values

Technical Rankings Surperformance